// App-Quantinova.ai

2565 : Joint cell-line and patient modeling of drug sensitivity reveals novel molecular biomarkers for targeted and conventional chemotherapy.

Researchers

Presenter

  • Charles Ferte

Principal Investigators

  • Elias Chaibub Neto

  • Frederic Commo

  • Antoine Hollebecque

  • Christophe Massard

  • Adam Margolin

  • Stephen Henry Friend

  • Fabrice Andre

  • Jean-Charles Soria

  • Mehmet Gonen

  • Ludovic Lacroix

  • Valerie Koubi-Pick

  • Eric Angevin

  • Benjamin Besse

  • Michel Ducreux

  • Justin Guinney

  • Olga Nikolovain Sock Jang

Medical Centers

  • Sage Bionetworks, Seattle, WA

  • Drug Development Department (DITEP), Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, FranceDepartment of Medical Oncology, Institut Gustave Roussy, Villejuif, FranceGustave Roussy, University Paris Sud, Villejuif, France

  • Institut Gustave-Roussy, Villejuif, France

  • Gustave Roussy, Villejuif, France

  • Institut Gustave-Roussy, Villejuif, France

  • Translational Research, Gustave Roussy, Villejuif, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Department of Biopathology. Gustave Roussy Cancer Campus, Villejuif, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Endometrial Cancer

  • Colorectal Cancer

  • Gynaecological cancer

  • Breast cancer

  • Solid malignancies

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved